Dual antiplatelet therapy versus oral anticoagulation plus antiplatelet monotherapy in patients with acute coronary syndrome and coronary artery ectasia: OVER-TIME randomized clinical trial

8 March 2024 (08:30 - 13:45)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Doctor Diego Araiza Garaygordobil

Instituto Nacional de Cardiologia Ignacio Chavez, Ciudad de Mexico (Mexico)

4 More presentations in this session

Presentation thumbnail

The basal level of inflammation during cardiogenic shock is a strong independent risk marker of mortality.

Professor F. Roubille (Montpellier, FR)

Presentation thumbnail

Prehospital risk assessment and direct transfer to a percutaneous coronary intervention centre in suspected acute coronary syndrome: 1 year follow-up of the TRIAGE-ACS study

Mr J. Demandt (Eindhoven, NL)

Presentation thumbnail

Early left ventricular unloading or conventional approach after venoarterial extracorporeal membrane oxygenation: One-year outcomes of the EARLY-UNLOAD randomized clinical trial

Assistant Professor Y. Lim (Gwangju, KR)

Presentation thumbnail

Targeted mild hypercapnia is associated with reduced hs-Troponin T release after acute myocardial infarction and out-of-hospital cardiac arrest. A sub-study of the TAME trial.

Doctor M. Baumann Melberg (Oslo, NO)

Access the full session

Session thumbnail

Late-breaking science

The Event

Event poster

ESC Acute CardioVascular Care 2024

8 March - 10 March 2024

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources